Clinical Trial Update: First-line Gefitinib Versus Chemotherapy for Lung Adenocarcinoma in Never Smoker [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing first-line Gefitinib versus chemotherapy in never-smokers with lung adenocarcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma
• Lung Cancer

Drugs mentioned

• Gefitinib (Iressa) (gefitinib)

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Lung Cancer | Phase 3 | Status: COMPLETED